Zandbergen, A.A.M.

patient albumin excretion rate losartan type 2 diabetes diabetes blood pressure albumin excretion study blood placebo pressure group microalbuminuria normotensive patients effect normotensive treatment placebo group 5 weeks reduction albumin excretion creatinine clearance mellitu 100 mg hypertensive patients baseline antagonist creatinine change hypertensive hospital antiproteinuric trial losartan group 50 mg clearance nephropathy placebo groups antiproteinuric effects level antiproteinuric effect end points 10 weeks angiotensin-receptor antagonists zeeuw disease zandbergen irbesartan inhibitor angiotensin-receptor mmol /l baggen article number period medicine ouwendijk difference analysis kidney 200 g /min netherland 150/90 mm hg nephrol dial transplant point 140/90 mm hg event baseline blood pressures ann intern med time course jong pe parving hh lambert kidney int hypertension medication antihypertensive m.g.a washout period